A Business at a Glance
0 of 5 daily views used (5 remaining). Sign up free for 10 daily views, or try AAPL for a full preview.
SCPFL operates in the Medical - Diagnostics & Research industry, Healthcare sector. Full business description from SEC filing not yet available.
| Metric | TTM | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|
| Revenue | 0 | - | - | 0 |
| Net Income | -4.5M | -4.5M | 72M | -4.3M |
| EPS | $-1.65 | $-1.65 | $26.53 | $-1.60 |
| Free Cash Flow | -4.6M | -4.6M | -6.3M | -5.5M |
| ROIC | -154.8% | -80.0% | - | -140.1% |
| Gross Margin | - | - | - | - |
| Debt/Equity | 0.00 | 0.18 | - | 2.56 |
| Dividends/Share | $20.53 | $20.53 | - | - |
| Operating Income | -6.9M | -6.9M | - | -2.6M |
| Operating Margin | 0.0% | - | - | - |
| ROE | -23.2% | -23.2% | - | -246.9% |
| Shares Outstanding | 3M | 3M | 3M | 3M |
| Metric | 2021 | 2022 | 2023 | TTM |
|---|---|---|---|---|
| Income Statement | ||||
| Revenue | 0 | N/A | N/A | 0 |
| Gross Margin | N/A | N/A | N/A | N/A |
| R&D | N/A | N/A | N/A | N/A |
| SG&A | N/A | N/A | N/A | N/A |
| EBIT | -2.6M | N/A | -6.9M | -6.9M |
| Op. Margin | N/A | N/A | N/A | 0.0% |
| Net Income | -4.3M | 72M | -4.5M | -4.5M |
| Net Margin | N/A | N/A | N/A | 0.0% |
| Non-Recurring | 0 | 0 | 0 | 0 |
| Returns on Capital | ||||
| ROIC | -140.1% | N/A | -80.0% | -154.8% |
| ROE | -246.9% | N/A | -23.2% | -23.2% |
| ROA | -31.5% | 156.6% | -8.8% | -18.5% |
| Cash Flow | ||||
| Op. Cash Flow | -5.5M | -6.3M | -4.6M | -4.6M |
| Free Cash Flow | -5.5M | -6.3M | -4.6M | -4.6M |
| Owner Earnings | -5.6M | -6.5M | -4.8M | -4.8M |
| CapEx | 0 | 0 | 0 | 0 |
| Maint. CapEx | 107K | 144K | 259K | 259K |
| Growth CapEx | N/A | N/A | N/A | 0 |
| D&A | 107K | 144K | 259K | 259K |
| CapEx/OCF | N/A | N/A | N/A | 0.0% |
| Capital Allocation | ||||
| Dividends Paid | 0 | 0 | 56M | 56M |
| Dividend Yield | N/A | N/A | 43.8% | 14.7% |
| Share Buybacks | 0 | 0 | 0 | 0 |
| Buyback Yield | 0.0% | 0.0% | 0.0% | 0.0% |
| Stock-Based Comp | N/A | N/A | N/A | N/A |
| Debt Repayment | 0 | 7.7M | 0 | 0 |
| Balance Sheet | ||||
| Net Debt | -210K | -73M | -12M | -16M |
| Cash & Equiv. | 4.7M | 75M | 16M | 16M |
| Long-Term Debt | N/A | N/A | N/A | N/A |
| Debt/Equity | 2.56 | N/A | 0.18 | 0.00 |
| Interest Coverage | -6.9 | N/A | -33.5 | -33.5 |
| Equity | 1.7M | N/A | 19M | 19M |
| Total Assets | 14M | 78M | 24M | 24M |
| Total Liabilities | 12M | N/A | 4.9M | 4.9M |
| Intangibles | 19K | 5K | 26K | 26K |
| Retained Earnings | -15M | 59M | -3.5M | -3.5M |
| Working Capital | 4.4M | 75M | 20M | 20M |
| Current Assets | 12M | 76M | 22M | 22M |
| Current Liabilities | 7.4M | 1.1M | 1.5M | 1.5M |
| Per Share Data | ||||
| EPS | -1.60 | 26.53 | -1.65 | -1.65 |
| Owner EPS | -2.09 | -2.41 | -1.77 | -1.77 |
| Book Value | 0.65 | 27.82 | 7.12 | 7.12 |
| Cash Flow/Share | -2.05 | -2.35 | -1.68 | -1.56 |
| Dividends/Share | N/A | N/A | 20.53 | 20.53 |
| Shares Out. | 2.7M | 2.7M | 2.7M | 2.7M |
| Valuation | ||||
| P/E Ratio | -21.3 | 1.7 | -30.1 | -84.7 |
| P/FCF | N/A | N/A | N/A | N/A |
| EV/EBIT | N/A | N/A | N/A | N/A |
| Price/Book | 52.6 | 1.6 | 7.0 | 19.7 |
| Price/Sales | N/A | N/A | N/A | N/A |
| FCF Yield | -6.0% | -5.2% | -3.4% | -1.2% |
| Market Cap | 91M | 123M | 136M | 382M |
| Avg. Price | 36.86 | 34.91 | 46.84 | 140.00 |
| Year-End Price | 34.04 | 45.64 | 49.84 | 140.00 |
SCPFL passes 2 of 9 quality checks, indicating weak fundamentals.
Total shareholder yield (dividends) is 14.7%. At current prices, the estimated annualized return to fair value is +1.8%.
SCPFL (SCP-WA) has a 5-year average return on invested capital (ROIC) of -110.0%. This is below average and may indicate limited pricing power.
SCPFL (SCP-WA) has a market capitalization of $382M. It is classified as a small-cap stock.
Yes, SCPFL (SCP-WA) pays a dividend with a trailing twelve-month yield of 14.67%.
SCPFL (SCP-WA) operates in the Medical - Diagnostics & Research industry, within the Healthcare sector.
SCPFL (SCP-WA) generated $-5 million in free cash flow in its most recent fiscal year. Negative free cash flow may indicate heavy investment or operational challenges.
SCPFL (SCP-WA) has a debt-to-equity ratio of 0.18. This indicates a conservatively financed balance sheet.
SCPFL (SCP-WA) reported earnings per share (EPS) of $-1.65 in its most recent fiscal year.
SCPFL (SCP-WA) has a return on equity (ROE) of -23.2%. A negative ROE may indicate losses or negative equity.
The Ledger Terminal provides 3 years of financial data for SCPFL (SCP-WA), sourced directly from SEC EDGAR filings. This includes income statements, balance sheets, cash flow statements, and key financial ratios.
SCPFL (SCP-WA) has a book value per share of $7.12, based on its most recent annual SEC filing.